4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-21-012571
Chief Scientific Officer sold 115,250 shares at an average $46.15 ($5,318,769)
- Chief Scientific Officer acquired 115,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Zago Wagner M. · Chief Scientific Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-22 | Exercise or conversion : show line 1 in the form | +15,000 | $20.17 | $302,550 | 15,000 | D |
| 2021-06-22 | Exercise or conversion : show line 2 in the form | +19,000 | $27.81 | $528,390 | 34,000 | D |
| 2021-06-22 | Exercise or conversion : show line 3 in the form | +81,250 | $15.04 | $1,222,000 | 115,250 | D |
| 2021-06-22 | Sale : show line 4 in the form | −65,840 | $45.42 | $2,990,249 | 49,410 | D |
| 2021-06-22 | Sale : show line 5 in the form | −26,106 | $46.27 | $1,208,037 | 23,304 | D |
| 2021-06-22 | Sale : show line 6 in the form | −18,101 | $47.81 | $865,498 | 5,203 | D |
| 2021-06-22 | Sale : show line 7 in the form | −5,203 | $49.01 | $254,986 | 0 | D |
| Open-market sales · 115,250 sh · avg $46.15 · $5,318,769 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-06-22 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −15,000 | $20.17 | 2023-09-03 | 15,000 | 0 | D |
| 2021-06-22 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −19,000 | $27.81 | 2025-03-11 | 19,000 | 0 | D |
| 2021-06-22 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −81,250 | $15.04 | 2028-06-21 | 81,250 | 68,750 | D |
Loading xslF345X03/doc1.xml…